Nerves, endothelial cells, and cells of the immune system produce a low molecular weight protein called substance P (SP). SP can modulate several important immunological functions (1) .
The NK1 receptor (SPr) is one of the three distinct mammalian tachykinin receptors (2) . SP is the only known high-affinity ligand for this receptor. The SPr is widely distributed throughout the body and is expressed on neurons, endothelial cells (3) , and other cell types. Lymphoid organs and immunocytes such as lymphocytes and macrophages can express SPr (4 -6) .
Recent publications implicate SPr in immune modulation and susceptibility to infection. Clostridium difficile is a bacterium that can release toxins that induce colitis. The SPr helps mediate the inflammatory diarrhea and mucosal injury induced by C. difficile toxin A (7). Mice with disruption of the SPr gene are less susceptible to immune complex-induced pulmonary injury (8) and interleukin 1 (IL-1)-induced neutrophil migration (9) . Mice given a SPr antagonist develop less severe central nervous system inflammation in response to Trypanosoma brucei infection (10) . Also, mice pretreated with SPr antagonist are more susceptible to intestinal salmonellosis and show a decreased interferon-␥ (IFN-␥) response in the intestine (11) .
In murine schistosomiasis mansoni, helminthic worms inhabit the portal and mesenteric veins. They produce ova that settle in the liver and intestines. The ova incite focal Th2-type, granulomatous inflammation.
Schistosome granulomas have a SP immunoregulatory circuit (12) . Schistosome granulomas contain SP (13) and express mRNA for preprotachykinin (12) , which is the precursor polypeptide for SP. Granuloma lymphocytes and other cellular elements express mRNA for SPr (5, 14) . In murine schistosomiasis, SP augments IFN-␥ secretion from antigen-stimulated splenocytes or granuloma cells through interaction with this receptor (15) . SPr antagonists given orally impede granuloma formation and interfere with IFN-␥-driven immunoglobulin G2a (IgG2a) expression, further suggesting a role for SP in the inflammation (16) . Studies using specific SPr antagonists or mice deficient in SPr showed the importance of this receptor in mediating the T-cell IFN-␥ response in murine schistosomiasis (14, 16) . SPr on neurons undergoes desensiti-zation in response to repeated SP exposure. SPr is displayed more prominently in inflamed tissue (17) . However, it is uncertain whether SPr is subject to induction or modulation at sites of inflammation.
Using murine schistosomiasis, we now show that both IL-12 and schistosome egg antigen (SEA) induce T cells to produce SPr. SEA, working independently of IL-12 and IFN-␥, incites SPr expression through interaction with T-cell receptor (TCR). IL-12 induces SPr independently of TCR activation and IFN-␥. This is the first demonstration that SPr is an inducible receptor on T cells. These data and previous findings also suggest that SP, a regulator of IFN-␥ production, is a component of the IL-12 immunoregulatory circuit that promotes IFN-␥ secretion and Th1-cell development.
MATERIALS AND METHODS

Mice and schistosome infection
This study used normal CBA and C57BL/6 mice purchased from (NCI, Bethesda, Md.). Also used were129 Sv ϫ C57BL/6 SPrϪ/Ϫ, C57BL/6 IL-4Ϫ/Ϫ, and C57BL/6 IL-12 p40/ IFN-␥R double-knockout mice. Breeding colonies for the mutant animals were maintained at the University of Iowa. At 7-8 wk of age, mice were infected subcutaneously with 50 cercariae of the Puerto Rican strain of Schistosoma mansoni.
Dispersal of granuloma cells and splenocytes, and cell culture
Livers of mice killed during the 8 wk of infection were homogenized for 30 s at low speed in a Waring blender. Granulomas were collected by 1g sedimentation and were washed three times in RPMI 1640 medium (RPMI). To prepare a single-cell suspension from these granulomas, the intact granulomas were incubated in a shaking water bath at 37°C for 30 min in RPMI containing 0.5% collagenase (type 1 from Clostridium histolyticum, Sigma Chemical Co., St. Louis, Mo.). The softened granulomas were disrupted further by repeated suction and expulsion through a 1 ml syringe. The dispersed granuloma cell suspensions were passed through a sterile gauze to exclude nondispersed fragments. The cells were collected by centrifugation, washed three times in RPMI, and counted. Cell viability was determined by eosin Y exclusion.
Single-cell suspensions of splenocytes were prepared from individual spleens from 8 wk infected mice by gentle teasing in RPMI. The cells were briefly resuspended in distilled water to lyse RBCs. The splenocytes then were washed three times in a large volume of RPMI.
Cells were cultured for 4 h in T25 flasks (Corning, Cambridge, Mass.) with 6 ml of medium (ϳ4ϫ10 7 cells/flask) at 37°C. The culture medium was RPMI containing 10% fetal calf serum (FCS), 10 mM HEPES buffer, 2 mM l-glutamine, 100 U/ml penicillin, 5 mg/ml gentamicin, and 100 mg/ml streptomycin (all from Sigma). The cells were cultured alone or in the presence of antigen (SEA) (5-0.5 g/ml), rIL-12 (5 ng/ml) (Peprotech, Rocky Hill, N.J.), rIL-10 (30 ng/ml), or rIFN-␥ (200 U/ml) (R&D Systems Inc., Minneapolis, Minn.). Some cultures also had anti-IL-12 monoclonal antibody (mAb) (2.5 g/ml) (Wistar Institute, Philadelphia, Pa.) or anti-Ia mAb HB26 (ϳ1 g/ml) (ATCC, Manassas, Va.). The SEA was made as described earlier (18) from ova isolated from the livers of hamsters infected for ϳ7 wk with 1000 cercariae. Ϫ splenocytes contained all the other leukocyte subsets normally expected in a spleen or a schistosome granuloma.
T-cell isolation
T-cell line
The D1.1 T cell line was maintained in T25 flasks in RPMI medium (Sigma) containing 10% FCS, 10 mM HEPES buffer, 2 mM l-glutamine, 100 U/ml penicillin, 5 mg/ml gentamicin, 100 mg/ml streptomycin, and 50 U/ml rIL-2 in 5% CO 2 at 37°C. For boosting, 6 ml of RPMI complete medium containing rabbit IgG (100 g/ml) was added to T25 flasks containing adherent D1.1 cells. Also added were irradiated (3000 rad) splenocytes (10 6 /ml). The cultures were split every 2-3 days and maintained in complete medium. Two weeks after boosting, the cells were cultured for 4 h in RPMI complete medium with or without rIL-12 (5 g/ml). After the incubation, cellular RNA was extracted for SPr mRNA measurement.
Flow cytometric analysis
Spleen cells were washed twice and adjusted to 2 ϫ 10 7 cells/ml in FACS buffer (HBSS containing 10% FCS and 0.02% sodium azide). The cell suspensions were then dispensed into microcentrifuge tubes each containing 10 6 cells in 50 l of FACS buffer. Each tube also received 1 g of 2.4G2 antibody (anti-Fc ␥ R) (ATCC) to block nonspecific binding of conjugated antibodies to Fc receptors. Cells were stained with saturating amounts of conjugated antibodies for 30 min at 4°C. The mAbs used for staining were anti-CD4-Cy5 (GK1.5) and anti-Thy-1.2-FITC (PharMingen, San Diego, Calif.). After cells were stained, they were washed twice and resuspended in 300 l of FACS buffer. Stained cells were analyzed on a Becton Dickinson FACS 440 flow cytometer (Mountain View, Calif.). Forward angle light scatter and three simultaneous immunofluorescence parameters were collected on 30,000 cells. The data were analyzed using FACS/DESK software.
RNA extraction and polymerase chain reaction (PCR) assay for SPr mRNA
Each experiment used RNA from splenocytes pooled from three or four separate mice. Total cellular RNA was extracted from cell suspensions by homogenization in guanidinium/ acid phenol as described previously (19) . Cellular RNA (5 g) was reverse transcribed with Moloney monkey leukemia virus (400 U) using an 18-mer of oligo-dT (0.5 g) as primer. The first-strand cDNA was diluted to 250 l, and 15 l (0.3 g of RNA) was added to PCR buffer containing 2 U of Taq DNA polymerase, 1.4 mM MgCl 2 , 50 mM KCl, and 100 mM Tris (pH 8.3) in a total volume of 50 l. The sense primer to amplify SPr was 5Ј-CCA ACA CCT CCA CCA AGA CTT CTG-3Ј and the antisense primer was 5Ј-GCC ACA GCT GTC ATG GAG TAG AT-3Ј. The PCR consisted of 40 cycles at 93°C for 1.1 min, at 63°C for 1.36 min, and at 72°C for 1.14 min.
Products of reverse transcriptase (RT)-PCR amplification were analyzed by agarose gel electrophoresis by using 1.7% NuSieve GTG agarose (FMC Bioproducts, Rockland, Maine) in 0.5ϫ TBE buffer. The authenticity of the 338-bp fragment was confirmed by sequencing.
Total RNA preparations contained equivalent 18S and 28S RNA bands. RNA extracts were quantified spectrophotometrically. In some experiments, samples were compared for content of actin to further confirm equivalent mRNA content and reverse transcription.
NK1 receptor (SPr) competitive PCR assay
The 338-bp NK1 PCR product was cloned into PgemTez (Promega, Madison, Wis.) and then cut with StuI. A 268-bp EcoRV fragment of cDNA was ligated into the StuI site of the NK1 sequence to create an elongated mimic sequence of 606 bp. The mimic plasmid was selected, expanded, purified, and then quantified by UV spectrophotometry. Various quantities of mimic plasmid DNA containing double-stranded elongated NK1 cDNA were added to a series of PCR reactions containing sample cDNA. The concentration of the unknown mRNA was determined through competition with known concentrations of this engineered plasmid by localization of bands of equivalence.
ELISAs
Cytokine concentrations in supernatants were measured by ELISAs. To measure IFN-␥, plates were coated with a mAb to IFN-␥ (HB170, ATCC) and incubated with supernatant. IFN-␥ was detected by using polyclonal rabbit anti-IFN-␥ (gift from Dr. Mary Wilson, Department of Medicine, University of Iowa) followed by biotinylated goat anti-rabbit IgG (Accurate Chemical Co., Westbury, N.Y.), streptavidin-horseradish peroxidase, and ABTS substrate (Zymed, San Francisco, Calif.). IL-4 was captured with 11B11 (HB191, DNAX Research Institute, Palo Alto, Calif.) and detected with biotinylated BVD6 (provided by Kevin Moore and John Abrams, DNAX). IL-5 was captured with TRFK5 and detected with biotinylated TRFK4 (provided by Dr. Robert Coffman, DNAX) followed by streptavidin-peroxidase conjugate. IL-12 p70 was captured with anti-IL-12 mAb MM-120 (Endogen, Woburn, Mass.), and IL-12 p40 was captured with anti-IL-12 mAb C15-6 (a kind gift from Dr. G. Trinchieri, Wistar Institute, Philadelphia, Pa.). C15-6 captured both free p40 and p40 bound to p35 (p70). Both p40 and p70 were detected with biotinylated anti-IL-12 mAb MM-121-B (Endogen) and HRP-conjugated streptavidin (Zymed). Sensitivities of the ELISAs were 30 pg/ml for IFN-␥, IL-5, IL-12 p70, and IL-12 total p40, and 100 pg/ml for IL-4.
The mAbs to IFN-␥ (HB170), IL-4, IL-5, and IL-12 (C15-6) were derived from cell lines maintained in our laboratory. These mAbs were purified from culture supernatants by ammonium sulfate precipitation.
Detection of SPr protein by Western blot
Dispersed cells (ϳ4ϫ10 7 ) were pelleted and dissolved in 1:1 vol of 2ϫ sodium dodecyl sulfate (SDS) buffer (1.54% TRIS, 20% glycerol, 2% SDS, 2% 2-mercaptoethanol, 0.1% bromphenol blue) at pH 6.8. Samples were stored at Ϫ70°C until used. The samples were boiled 15 min before loading on a 10% bis-tris gel. The samples were electrophoresed at 200 V. Next, the samples were transferred from the gel to a 0.2 m PVDF membrane (Novex, Carlsbad, Calif.), as suggested by the company. The membrane was blocked overnight at 4°C in phosphate-buffered saline (PBS) containing 5% milk and 0.1% Tween. Then the membrane was exposed to anti-SPr IgY Ab at 1:1000 dilution for 1 h at room temperature. The antibody, which was a kind gift from Dr. Kenneth Bost at the University of North Carolina, Charlotte, N.C., was prepared as described previously (20) . The membrane was washed four times with PBS containing 0.1% Tween and then exposed to peroxidase-conjugated donkey anti-chicken Ab (Jackson Immune Research Laboratories, West Grove, Pa.) at 1:1000 dilution for 1 h at room temperature. Once more the membrane was washed four times with PBS/0.1% Tween followed by two washings in PBS/0.5% Tween. The membrane was exposed to Opti 4CN substrate (Bio-Rad, Hercules, Calif.) for visualization of the immunoreactive bands.
Statistical analysis
Data are means Ϯsd of multiple determinations. Difference between two groups was compared by using Student's t test. P values Ͻ0.05 were considered significant.
RESULTS
Induction of SPr mRNA expression
Splenocytes from mice infected with S. mansoni, cultured in vitro for up to 18 h, did not express SPr mRNA or did so weakly, as determined by a sensitive quantitative RT-PCR assay. This assay could detect SPr mRNA at the concentration of ϳ100 SPr mRNA transcripts/g of total RNA.
Splenocytes then were cultured with SEA for 4 h, and RNA was extracted, reversed transcribed, and assayed for SPr cDNA content. SEA even at low concentrations strongly induced expression of SPR mRNA (Figs. 1A  and 2 ). This induction resulted in SPr mRNA levels were cultured for 4 h in flasks at 37°C with or without A) SEA (5 or 0.5 g/ml); B) rIL-12 (5 ng/ml), rIL10 (30 ng/ml), or rIFN-␥ (200 U/ml); or C) SEA (5 g/ml) or SEA plus anti-IL-12 mAb (2.5 g/ml). After the incubation, splenocyte RNA was extracted, reverse transcribed, and amplified by PCR for SPr cDNA. Also amplified were known amounts of the plasmid control that contained the lengthened SPr sequence used in the competitive PCR assay. MW signifies the molecular weight standards. Data represent four or more experiments. The quantitative results are expressed in Fig. 2. greater than 100-fold higher than those of the unstimulated splenocytes. PCR amplification always yielded the predicted, single 338 bp fragment characteristic of SPr mRNA. The authenticity of the 338 bp fragment was confirmed by sequencing (data not shown).
Splenocytes cultured for 4 h with rIL-12 also expressed SPr mRNA strongly, a greater than 100-fold increase over basal conditions (Figs. 1B and 2 ). This strong induction required as little as 10 pg/ml rIL-12. However, neither rIL-10 nor rIFN-␥ induced SPr mRNA.
SEA induction of SPr mRNA is independent of IL-12 and IFN-␥ but dependent on class II interaction
Because both SEA and rIL-12 could induce SPr mRNA expression in dispersed splenocytes, we investigated whether SEA requires IL-12 for SPr stimulation. Splenocytes were cultured for 4 h with or without SEA. Some cultures also contained neutralizing anti-IL-12 mAb. The anti-IL-12 mAb did not prevent SEA from inducing SPr mRNA (Figs. 1C and 2) . The mAb used alone had no affect on SPr expression. The mAb was used at a concentration that completely blocked the biological activity of at least 300 pg of rIL-12, as determined by bioassay. Splenocytes cultured with SEA (5 g/ml) for up to 48 h secreted no detectable IL-12 (Ͻ30 pg/ml).
Other experiments used the IL-12 p40 and IFN-␥R double-mutant mouse to further address the relevance of IL-12 in SEA induction of SPr. These mice were appropriately colonized with S. mansoni and formed IFN-␥, IL-12 p40, or IL-12 p70, as measured by sensitive ELISAs, even after appropriate stimulation. SEA still strongly stimulated SPr expression in splenocytes from these double-knockout animals (Fig. 3A) .
SEA is a soluble extract of schistosome ova. It contains antigenic determinants of the schistosome egg that stimulate T cells from infected mice to secrete various cytokines. Experiments examined whether SEA induction of SPr mRNA was likely dependent on TCRclass II interactions. Splenocytes from infected mice were cultured with SEA with or without blocking anti-Ia mAb. Figures 2 and 3B show that blocking anti-Ia mAb prevented SEA from inducing SPr mRNA. Also, SEA failed to induce SPr expression in splenocytes from mice without schistosomiasis, which suggests that SPr mRNA induction was an antigen-specific response.
IL-12 induces SPr mRNA expression independently of IFN-␥
IL-12 is an important inducer of IFN-␥ production. We investigated whether rIL-12 stimulates SPr mRNA expression independently of IFN-␥. Unlike rIL-12, rIFN-␥ could not induce SPr mRNA expression in splenocytes from schistosome-infected mice (Fig. 1B) . IL-12 remained a strong inducer of splenocyte SPr mRNA even in the IL-12 p40 and IFN-␥R double-knockout mouse, an animal with highly impaired IFN-␥ circuitry (Fig. 3A) .
SPr mRNA localizes to splenic T cells
Additional studies identified the splenocyte subset expressing SPr mRNA after the 4 h exposure to either were cultured for 4 h in flasks at 37°C with or without SEA (5 g/ml) and/or anti-Ia mAb (1 g/ml). After the incubation, splenocyte RNA was extracted, reverse transcribed, and amplified by PCR for SPr cDNA. Also, amplified were known amounts of a plasmid control that contained the lengthened SPr sequence used in the competitive PCR assay. MW signifies the molecular weight standards. Data represent four experiments. The quantification results are shown in Fig. 2 . Figure 2 . The concentration of SPr mRNA in spleen cell preparations after exposure to rIL-12 or SEA. Splenocytes were cultured for 4 h at 37°C with or without rIL-12 (5 ng/ml), SEA (5 g/ml), rIL-10 (30 ng/ml), rIFN-␥ (200 U/ml), anti-IL-12 (␣IL12) (2.5 g/ml), anti-Ia (␣Ia) (1 g/ml), SEA (5 g/ml) plus anti-IL-12 (2.5 g/ml), or SEA (5 g/ml) plus anti-Ia (1 g/ml). After the incubation, cellular RNA was extracted and subjected to quantitative RT-PCR analysis to measure the number of SPr mRNA transcripts. Data are means Ϯ sd of three to five separate experiments.
SEA or rIL-12. Splenocytes were incubated in vitro for 3.5 h with or without SEA or rIL-12. The splenocytes then were separated within 40 min into Thy-1.2 ϩ and Thy-1.2 Ϫ , or CD4 ϩ and CD4 Ϫ , subsets by using paramagnetic bead isolation. The fractionated splenocytes were examined by flow cytometry during each experiment to ensure adequate separation. This technique routinely resulted in Ͼ99% removal of the desired cell subset from unfractionated, whole splenocytes (Fig. 4) . RNA was then extracted from the bead-adherent Thy-1.2 ϩ or CD4 ϩ T cells and from the nonadherent Thy-1.2 ϩ -or CD4 ϩ -depleted splenocytes. Once more, only splenocytes exposed to SEA or rIL-12 expressed SPr mRNA. There was little or no constitutive expression without SEA or rIL-12 exposure. The induced SPr mRNA localized to the Thy-1.2 ϩ subset, and none was detected in splenocytes depleted of Thy-1.2 ϩ T cells (Fig.  5A) . Also, more than 90% of the SPr mRNA migrated with the CD4 ϩ T-cell subset (Fig. 5B) . Isolated splenic Thy-1.2 ϩ or CD4 ϩ T cells had much higher concentrations of SPr mRNA, relative to total RNA, than unfractionated splenocytes (Figs. 2 and 5 ).
IL-12 induces SPr mRNA expression in the D1.1 T cell line
Experiments used the D1.1 T cell line to determine whether IL-12 could act directly on T cells to induce SPr. This cell line does not express SPr mRNA if grown under the conditions outlined in the Methods section. Figure 6 shows that brief exposure to rIL-12 can induce SPr mRNA expression in D1.1 T cells. As expected, SEA had no effect.
Splenic T cells contain SPr protein after SEA or rIL-12 exposure
Also examined was the effect of SEA and rIL-12 on SPr protein expression in splenocytes of schistosome-in- fected mice. Splenocytes were incubated for 5 h with SEA or rIL-12 to induce SPr mRNA expression. The cells then were fractionated into Thy-1.2 ϩ and Thy-1.2 Ϫ subsets followed by protein extraction and solubilization with SDS. The Western blot analysis used a highly specific SPr Ab that recognized SPr protein in normal brain extracts but not in brain extracts from the SPr knockout mouse (data not shown). Figure 7 shows that Thy-1.2 ϩ T cells expressed the appropriate MW SPr protein after SEA or rIL-12 exposure. There was little SPr protein in splenocytes depleted of Thy-1.2 ϩ cells or in splenocytes cultured without SEA or rIL-12.
Granulomas and the SPr
In schistosomiasis, granulomas form around ova that deposit in the liver and intestines. The granulomas persist for many weeks. These granulomas contain various activated inflammatory cell subsets chonically exposed to SEA, IL-12, and other immunoregulatory molecules. We therefore studied isolated, dispersed granuloma cells to determine whether these activated T cells express SPr mRNA.
Unlike the resting splenocytes, the dispersed granuloma cells expressed SPr mRNA constitutively, as shown by RT-PCR (8015Ϯ983 SPr transcripts/g of total granuloma cell RNA, Ϯsd, nϭ2). Granuloma cells were fractionated into Thy-1.2 ϩ and Thy-1.2 Ϫ subsets by using paramagnetic beads. Flow cytometry confirmed the purity of these preparations. Unlike the location of SPr mRNA in the splenocytes, the SPr mRNA localized to both Thy-1.2 ϩ and Thy-1.2 Ϫ subsets, which suggests that SPr is expressed by both T-cell and non-T-cell elements in the granuloma (Fig. 8) . Granuloma cells were also cultured in vitro using the splenocyte protocol with or without rIL-12, SEA, or various other agents. There were no significant alterations in the already high level of SPr mRNA expressed in granuloma cells resulting from these manipulations (Fig. 8) .
DISCUSSION
Schistosome granulomas have a SP immunoregulatory circuit (12) that augments IFN-␥ secretion from antigen-stimulated splenocytes or granuloma cells through interaction with an authentic SPr (15) . SP is important in murine schistosomiasis, because SPr antagonists given orally impede granuloma formation and interfere with IFN-␥-driven IgG2a synthesis (16) . Studies using mice deficient in SPr have confirmed the importance of this receptor in mediating the T-cell IFN-␥ response in murine schistosomiasis (14, 16) .
The results presented here suggest that SPr mRNA is not constitutively expressed in T cells but is inducible by T-cell stimulation. Two factors that induced this expression are SEA and IL-12.
SEA stimulation appeared to require TCR-class II interactions, because anti-Ia mAb blocked SEA-induced SPr mRNA expression. SEA did not stimulate SPr mRNA expression in T cells from uninfected mice, which further supports this contention.
SEA remained a strong inducer of SPr mRNA even in the IL-12 p40 and IFN-␥R double-knockout mouse, which shows that SEA did not require either IL-12 or IFN-␥ production to induce this receptor. This result was confirmed by other experiments showing that neutralizing anti-IL-12 mAb could not block SEA induction of SPr mRNA. 4ϫ10 7 ) were cultured for 4 h in flasks at 37°C with or without rIL-12 (5 ng/ml), rIL10 (30 ng/ml), rIFN-␥ (200 U/ml), anti-IL-12 mAb (2.5 g/ml), rTGF-␤ (500 pg/ml), or SEA (5 g/ml). After the incubation, splenocyte RNA was extracted, reverse transcribed, and amplified by PCR for SPr cDNA. Data represent three separate experiments.
Because SPr can regulate IFN-␥ production in the granulomas and spleens of mice with schistosomiasis, we studied whether IFN-␥ could affect receptor expression. Recombinant IFN-␥ did not induce SPr mRNA in either splenocytes or dispersed granuloma cells. The data also suggest that IL-12 stimulation of SPr mRNA worked independently of IFN-␥, because IL-12 remained a strong stimulus for SPr expression in splenocytes from the IL-12 p40 and IFN-␥R double-knockout mouse.
Additional experiments explored the cellular source of splenic SPr mRNA after SEA or IL-12 receptor induction. These studies suggested that Thy-1.2 ϩ splenocytes were subject to this regulation. Also, most, but not all, SPr mRNA localized to cells expressing CD4. Flow cytometry confirmed the thoroughness of cell isolation, and we concluded that SPr mRNA was induced in splenic CD4
ϩ T cells and probably some CD8 ϩ T cells as well. Experiments also showed that IL-12 induces SPr mRNA expression in the D1.1 T cell line, which further supports this contention. The latter studies also demonstrated that IL-12 could work directly on T cells to induce SPr mRNA.
Western blot analysis, using an antibody highly specific for SPr, showed that splenic T cells express SPr protein strongly after exposure to SEA or rIL-12. Thus, the effect of SEA and rIL-12 on SPr mRNA within T lymphocytes leads to receptor protein expression within these cells. Trace amounts of SPr protein were evident in unstimulated splenocytes in the absence of detectable receptor mRNA, suggesting that some splenocytes may constitutively express SPr at low levels.
Previous studies revealed that splenocytes and granuloma cells from CBA mice produce IFN-␥ in response to SEA (15, 21) . SP used at 10 -9 M greatly enhances this stimulation (15) . The IFN-␥ is likely of T-cell origin (21) . Various specific SPr (NK1) antagonists completely inhibit the effect of SP on IFN-␥ secretion (16) . This result suggests that SPr mediates SP stimulation of IFN-␥ synthesis. Because SEA induces SPr expression on splenic T cells, which appear to be the predominant cell subset expressing SPr after SEA exposure, it is likely that SP regulates IFN-␥ production through direct interaction with T cells in the granulomas and spleens. Recent evidence also suggests that SP can enhance IFN-␥ production indirectly through inhibition of transforming growth factor ␤ (TGF-␤) production by macrophages (22) . However, in murine schistosomiasis, SP does not appear to alter either active or latent TGF-␤ secretion from dispersed granuloma cells or splenocytes cultured in vitro (unpublished observation).
In murine schistosomiasis, the parasite lives in the mesenteric veins and produces eggs that settle in the liver and intestinal wall. The ova release antigens (SEA) and other factors that induce a focal granulomatous response that surrounds and eventually destroys the egg. The inflammation is chronic and is composed of T cells, B cells, macrophages, eosinophils, and other cell types. The granulomas represent strong Th2 responses producing large amounts of IL-4 and IL-5. They also make IL-12 and some IFN-␥.
Both the activated T-cell and the non-T-cell elements of the granulomas in murine schistosomiasis express SPr mRNA. We and others previously showed that murine lymphocytes can express SPr mRNA (5, 23) . Other reports suggest that macrophages (11, 24) , vascular endothelial cells (3) , and other cell types express SPr. There is an SPr gene constitutively expressed in many mononuclear cells scattered throughout the granuloma (14) . We speculate that granuloma macrophages, which make up ϳ30% of the cellular composition of the granuloma, are at least one additional source of this signal.
Unlike the situation with splenocytes, brief exposure to SEA or IL-12 did not appear to further up-regulate the already strong SPr mRNA expression in dispersed granuloma cells. SPr is expressed naturally and is more widely distributed in the granuloma than in the spleen, so it is possible that regulation was not observed because of the complex nature of the cell preparations studied. SPr may be a persistant feature of activated T cells as well as some other inflammatory cell subsets that are chronically exposed to antigen, IL-12, and/or other inflammatory mediators.
SP and its receptor appear to be part of the Th1/Th2 immunoregulatory circuit. Inflammation tends to polarize into Th1-or Th2-type responses. The Th1 response makes large amounts of IFN-␥ and IL-2, whereas the Th2 reactions express IL-4, IL-5, and IL-13. However, this polarization is not absolute. In murine schistosomiasis, which is a strong Th2 response, SP stimulates IFN-␥ secretion from the splenic and granuloma CD4 ϩ T cells (21) . It does not appear to affect IL-4 or IL-5 synthesis.
Accumulating evidence suggests that SP helps maintain the low-grade IFN-␥ response within the strong Th2-type inflammation of murine schistosomiasis. SP stimulates IFN-␥ secretion from splenocytes and dispersed granuloma cells cultured in vitro (15) . In schistosomiasis, there is a marked impairment in IFN-␥ synthesis in the SPr Ϫ/Ϫ mouse (14) . Also, mice treated with an SPr antagonist form schistosome granulomas that produce less IFN-␥ (25) .
IL-12 promotes Th1 cell development by inducing IFN-␥ synthesis in T cells and natural killer cells (26, 27) . We conclude that, in murine schistosomiasis, IL-12 and SEA induce SPr expression on T cells. This, in turn, allows SP to amplify IFN-␥ production (Fig. 9) . It is tempting to speculate that this IL-12/SP system also operates in other inflammatory states and at mucosal surfaces that are rich in SP.
IL-12 is a component of the innate immune response, whereas TCR activation is part of adaptive immunity. We showed here that T-cell SPr can be induced by either innate or adaptive immune mechanisms. A defensive immune response calls into play various overlapping protective immunological pathways to ensure protection from highly adapted invading microorganisms. Thus, it is not surprising that there are 
